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ABSTRACT 
 
Introduction 
Headache disorders are prevalent in society and the number of adults suffering with an 
active headache disorder is increasing. Unfortunately the magnitude of this problem has 
been underestimated, and this has resulted in many headache sufferers being misdiagnosed 
or sub-optimally managed. Headache is a very common problem that is seen during primary 
health care consultations and should thus be given the priority it deserves. The aim of this 
study was to determine the prevalence and types of headaches seen at a district hospital. 
Methods 
A quantitative cross-sectional study was conducted at the Out-Patient Department of Dr 
Yusuf Dadoo Hospital which is located in the West Rand District, South Africa. Of the 206 
participants approached, 203 consented to participate in the study. The ICHD-II criteria were 
used to guide diagnosis of the participants. Consecutive study sampling was used for a 
period of just under 6 months. Results were reported as frequencies and means, and Chi-
squared tests were carried out.   
Results 
The response rate was 98.5%. Primary headache disorders were more prevalent compared 
to secondary headache disorders (69.95% vs. 30.05%). Fifty four percent of the participants 
suffered from tension type headache. Infections were the commonest cause of secondary 
headache disorders (34%). Middle aged black females were most commonly affected by the 
headache disorders. Tension headache is three times more likely to be seen in an 
unemployed participant than an employed person (OR-3.2, p-0.01, 95% CI: 1.50-7.08). Non-
infectious secondary headache disorders are 14 times more likely to be seen in those who 
are White than those who are Black (OR- 13.8, p-0.015, CI. 1.67-114.14). 
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 Conclusion 
Headache disorders are a significant cause of morbidity among those who attend the OPD 
of Dr. Yusuf Dadoo hospital and more needs to be done in addressing this issue. Further 
studies should be embarked on with the aim of closely looking at the psychosocial impact 
headache disorders have on patients.  
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CHAPTER 1 
INTRODUCTION 
1.1 Background and rationale for the research:  
 
Headache is a serious problem that requires attention from clinicians. Its impact and 
prevalence have been growing, with reports of global percentages of adults suffering with an 
active headache disorder being 46% for headache in general, 11% for migraine, 42% for 
tension-type headache and 3% for chronic daily headache1. Despite the high numbers of 
patients suffering with a headache disorder, the magnitude of the problem has been 
underestimated. This has, unfortunately, resulted in the problem being sub-optimally 
managed and under-recognized. It is also a well documented fact that headaches can be 
disabling and result in huge socio-economic problems for those affected by them1, 2. This is 
another important reason why their impact should not be taken lightly especially because 
some studies have reported prevalence rates that are between 60-80%22,,25,26.  
 
A high percentage of headache patients will present to primary health care 
physicians/General practitioners (GP’s) 3. In the United Kingdom, the most common 
neurological condition that patients present with, to GP’s, is headache4. Many of these 
patients will, unfortunately, be under-treated due to incorrect diagnosis3. Despite a headache 
lifetime prevalence of 82.7%, in Singapore, and a prevalence rate of 9.3% for patients 
suffering with a migraine type headache, diagnosis and treatment of the condition is sub-
optimal among primary care doctors5. This raises an important question: If more developed 
countries are facing challenges with regard to the diagnosis and treatment of headache 
disorders, how much bigger are the challenges in less developed countries like South 
Africa?   
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Primary health care providers working in primary care settings need to be aware of the 
burden of headache (type and prevalence) and its effects on those attending their respective 
health facilities. This will, however, not be possible without correct diagnosis of the problem. 
Such knowledge is important as it allows more effective interventions to be instituted, in an 
attempt to optimally help the affected patients5. Unlike the more developed countries, 
developing countries (sub-Saharan Africa in particular), have not provided enough data 
describing the magnitude of the problem of headache6. There is, therefore, a need for more 
studies that will not only describe the extent of the problem but those that will also provide 
information on the most common types of headaches seen in our setting.  
1.2 Motivation for the study 
 
Dr. Yusuf Dadoo Hospital is a level 1 hospital serving a large population (2 million people) in 
the West Rand district. An average of 80-100 patients present daily to the OPD of the 
hospital, presenting with various problems, headache being one of the commonest 
complaints. An assessment evaluating the prevalence and types of headache disorders that 
adult patients present with at the OPD of Dr. Yusuf Dadoo Hospital has, unfortunately, not 
been done. There is a paucity of studies in South Africa around the subject of Headache at a 
PHC Level, especially regarding the types of headache and socio-demographic features 
associated with the headache. Little is known about the burden of this problem on the 
population presenting to this facility. This study will, thus, establish the extent of this problem 
and thus contribute to the growing literature on this topic. Establishing the extent of this 
problem will also allow more effective interventions in the form of guidelines/protocols to be 
put in place. This will, hopefully, enable primary health care practitioners in South Africa to 
better manage patients presenting with headache. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Introduction 
 
Among disorders of the nervous system, headache is one of the commonest presentations 
to health care workers. It affects different types of populations making it a pervasive problem 
that should not be ignored. In addition to this, those affected by headache disorders tend to 
experience significant disability1. A third of those who suffer with migraine, in the UK, 
consider it a serious problem – enough to control their lives. Sixty six percent of the same 
population felt that the problem creates substantial morbidity “that they cannot control it at all 
or, at best, rarely.”2  
2.2 Prevalence according to headache type   
 
Tension type headache and migraine are the commonest headache disorders, accounting 
for 75% of all headache disorders11. A study conducted in a headache specialist centre in 
Canada, found migraine (45.3%) to be more prevalent than tension type headache (7.9%) 
among patients referred to the centre15.  This is in contrast to a study conducted in a primary 
health care centre where tension type headache and migraine had the same prevalence17. 
The World health organization reports tension type headache to be more common than 
migraine headache among those consulting in primary health care centres – 35% vs. 
30%11. About 10% of patients have combined migraine and tension type headache.  
Migraine is, however, reported to be the commonest diagnosis made by neurologists – 
34% (migraine) vs. 23% (tension type). There is therefore a difference between the 
prevalence of these two types of headache disorders in primary health care centres and 
headache specialist centres. While most of the primary headaches are acute or paroxysmal 
in nature, about 3% of headache sufferers have primary chronic headache which is defined 
as more than 15 headache days per month2. A study conducted in Norway, looking at the 
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management of primary chronic headache in the general population found it’s prevalence to 
be high. Twenty two percent of the men and 78% of the women who participated in the study 
were primary chronic headache sufferers. Ninety five percent had chronic tension-type 
headache, 4% had chronic migraine, and 2% had other primary chronic headache disorders. 
Forty nine percent had migraine as a co-morbidity and 46% suffered from medication 
overuse headache2. 
A large study conducted in Britain with 91,121 study participants found headache prevalence 
to be high among the study population3. Cluster headache had a prevalence of 4.0%, 
Tension-type 23.0% and Migraine 73.0%. Six percent of the patients were diagnosed with 
secondary headache. Unfortunately 70.1% did not receive a definitive diagnosis. Another 
study conducted in Europe also found the prevalence of migraine and tension type 
headache to be relatively high (migraine 17.9%, tension-type headache 13.3%, Migraine + 
Tension-type headache 12.8%)13. Unclassifiable headache was found to be 14.6% in 
prevalence. Another European study confirmed high percentages of headache disorders in 
the population, ranging from between 70% to over 90%29. 
In Africa the pattern seems to be similar. In a group of textile mill workers, in Ethiopia, the 
prevalence of Migraine headache was found to be 6.2%. Females had a prevalence of 
10.1% compared to males (3.7%).  Overall, the prevalence of tension-type headaches was 
found to be 9.8% (16.3 % in females and 5.7% in males)10. Another study conducted in 
Addis Ababa found the overall one year prevalence for tension type headache to be 10.4%, 
compared to 10% for migraine6. The prevalence of cluster headache was low (1.3%). In rural 
Tanzania the prevalence of migraine headache was found to be as high as 5%12. These 
figures are in the same range as those found in other continents, re-enforcing the fact that 
primary headaches (especially tension type headache and migraine headache) are more 
common than secondary headaches. In Zambia the prevalence of TTH was the same as that 
of migraine27 while in India TTH was slightly more prevalent than migraine28.  The World 
health Organization reports other headache disorders to be less common, together 
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accounting for 25% of headache disorders (other secondary headache – 9%, medication 
overuse headache – 9%, cluster headache – 2%, other – 6%)11.  
2.3 Types of headache 
 
In order to effectively care for the headache patient awareness of the problem, correct 
recognition and diagnosis need to be recognised as essential components in the medical 
management15. Knowledge of the classification of headache is therefore important. The 
ICHD-2 classifies headache into primary and secondary headache disorders.  Primary 
headaches are migraine, tension type headache, cluster type and other autonomic 
cephalalgias and other primary headaches16. An attachment giving a more extensive 
description of both primary and secondary headaches is found in Annexure 6. The ICHD-III 
beta version has recently been published with the final draft still to be confirmed21. 
2.4 Prevalence of headache among students 
 
Headache disorders are prevalent among various types of populations. A cross-sectional 
descriptive study was conducted in 2010 among six randomly selected secondary schools in 
Nigeria. This study, which had one thousand six hundred and seventy-nine participants(aged 
between 11 and 18 years), assessed the prevalence and influence of headache disorders in 
this population of Nigerian students. While previous studies8 of headache prevalence, in 
Nigeria, had focused on the adult population this study was the first of its nature – focusing 
on secondary school students. The study found the overall prevalence of headache to be 
19.5%7. 
 
In 2009 another prevalence study was conducted in Lagos, Nigeria, on an older population 
of students8. In contrast, the prevalence of headache, among the medical students 
participating in this study was much higher, at 46%. This cross-sectional survey included 376 
undergraduate students in the second to sixth year of their medical studies who completed a 
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structured questionnaire. Females were found to have a higher prevalence of headache 
compared to men (62.8% vs. 38.1%)8.  
 
Compared to African students, a pilot study conducted in America found the prevalence of 
headache to be 50.9% among 104 college students9. The fact that in all 3 of the above 
mentioned studies the prevalence of headache was found to be significantly high among the 
students has important implications. The students’ quality of life is impacted and they are 
also unable to engage in leisure or outdoor activities. There is also a high rate of school 
absenteeism7.  
2.5 Prevalence among workers 
 
Another important group of people that can be impacted by headache disorders is workers, 
as seen in a study conducted in Ethiopia10. All the workers in Akaki textile mill were included 
in this study. 1105 of the 1300 (85%) employees agreed to participate in the study. The 
researchers found the overall 1-year prevalence to be 16.4% for primary headaches. The 
one year prevalence of all types of headaches, however, was 73%. Females were found to 
have a higher prevalence of headache disorders, compared to males (one year prevalence 
of headache 79.2% vs. 69.5%; primary headache prevalence 26.9% vs. 9.1%). Those 
between the ages of 45 to 54 years had a prevalence of 18%10 . In Enugu, Nigeria, among 
health care workers, the prevalence of headache was 88%31. Primary headaches were more 
prevalent (71% among males and 76.4% among females). Twelve percent reported that the 
headache was strong enough to wake them up from sleep31. 
2.6 Prevalence in other countries 
 
In contrast to Africa, the problem of headache has been given the attention it deserves in 
European countries like Germany13. A large study conducted over a period of 3 years, 
looked at the prevalence of primary headaches in Germany. A validated questionnaire using 
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the IHS diagnostic criteria was used.  41.8% of the study population did not have any 
headache problems. 55.5% complained of headache less than fifteen days in a month, while 
2.6 percent complained of headache more than fifteen days in a month. Overall women had 
a higher prevalence of headache disorders compared to males13. A study looking at the 
impact of headache on the quality of life, in Turkey found the prevalence to be high – 
78.2%34. In Italy the life time prevalence of headache was reported to be 82.5% and the 
same study reported a 1 year prevalence of 74.2%25. 
In South America countries like Brazil have also recognized the importance of studying the 
burden of headache disease among its population14. A study was conducted in Vitoria ES, 
Brazil, looking at prevalence of headache symptoms, possible causes, nature of assistance 
that the headache sufferers seek and use of analgesics among the inhabitants who suffer 
with headache.  Fifty three percent of the study participants were found to be headache 
sufferers. Most of these were women compared to men (62.6% vs. 38.6%). Among those 
who are over 55 years old the prevalence of headache was significantly lower (p<0.001).  
The prevalence of headache was, however, higher among participants who are under the 
age of 30 years compared with those who are over 30 years of age (p<.025)14. Another 
study carried out in Brazil, investigated the main reason for consultation among those 
attending a family health care unit and found that 10.4% of the participants complained of 
various headache disorders24.  
In Bangalore India the 1 year prevalence was 62% and the 1 day prevalence was 5.9%22. 
Another study carried out in India found the 1 year prevalence to be 63.9%28. In 2012 a 
study carried out in Iran was published and it reported a prevalence of 78.2% of primary 
headaches. Surprisingly migraine disorders were more prevalent than TTH disorders (41.6% 
vs. 31.6%)47. In a large population based prevalence study, carried out in the United states 
of America, 17.3% of the participants were reported to be suffering from severe migraine 
headaches37.  
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2.7 Prevalence in Africa 
 
A study published in 2011, conducted by experts of the World health Organization and Lifting 
the burden, found headache prevalence to be 21.6% in the continent of Africa11. Compared 
to other continents/regions, this was the lowest figure (Americas – 46.5%, Eastern 
Mediterranean – 78.8%, Europe – 56.1%, South East Asia 63.9%, Western Pacific -52.8%). 
The problem, however, is that in Africa most countries did not submit data (only 39% of 
countries submitted data). Hence, the problem of headache prevalence in Africa might be 
underestimated, especially among patients who present to primary care settings. The same 
study also found that 58% of Africans affected by headache disorders self treat, instead of 
seeking help from a clinic or GP. This is compared to 20% who consult with primary care 
physicians and 15% who consult with neurologists11.  
 
A study published in 2004 found that 23.1% of the 3351 participants living in a rural area in 
Tanzania suffered from a headache disorder the year before the study was undertaken. Five 
percent of these had suffered from a migraine attack12. Another study carried out in Addis 
Ababa Ethiopia, in an urban setting, also looked at the prevalence of primary headaches 
among 231 participants10. Twenty six percent of these participants were found to have a one 
year prevalence of primary headache disorders. There was no difference in prevalence of 
primary headache disorders between males and females (21.8% vs. 21.4%). Recently 
published studies (2014 & 2015) showed a moderately high prevalence (72% in the past 
year and 28.3% on the day prior to the interview) in Zambia27,39, in a door to door survey and 
in Nigeria among health care workers (88% in the past six months)31. (At the time of writing 
no studies were found that directly address the prevalence of headache among patients 
seen in a primary health care setting in South Africa). 
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2.8 Socio-demographic aspects of headache 
 
As shown above females are more affected by headache disorders compared to 
males7,8,10,14. The percentage ranges from 60-75% of females who present with headache 
disorders (this includes both primary health care centres and specialist headache centres).  
Those between the ages of 20 to 60 years frequently consult for headache disorders11. 
Primary headache disorders are diagnosed in those between the ages of 35-44, while 
secondary headache disorders are diagnosed in those who are 55 years and older15.  
 
A study conducted in a specialist headache centre found 90% of patients to have at least 
a high school diploma, while 22% were educated to a Bachelor degree level or higher10. 
61.9% of the patients were employed outside of the home, while 9.3% were unemployed. 
This finding is in contrast to another study conducted in the general population which 
found the prevalence to be similar across all occupations, suggesting that headache 
disorders can affect anyone11. A study carried out in the United States reported a high 
prevalence of headache among those with a low level of education40.  
 
Studies done in the US have suggested that some headache disorders are more common 
among Caucasians compared to African-Americans18. African-Americans have, however, 
been reported to suffer from more frequent and severe headaches than Whites18. In South 
Africa, unfortunately, no studies have been done looking at headache prevalence by race.  
 
A study looking at the prevalence of headache in the elderly population found that 16.9% of 
the participants had onset of headache after the age of 64 years19. 51% were significantly 
affected by primary headache disorders. The 1 year prevalence of those with headache was 
higher in women compared to men. It, however, decreased from the 65–74 through the 85–
96 age group19. Marital status also seems to play a role in whether individuals were more 
affected by headache disorders10.  
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In a study conducted in Ethiopia widows and divorced individuals had a significantly higher 
proportion of all types of headaches10. Individuals suffering from primary headaches also 
tend to miss working days more frequently (34.8% of individuals studied) and have a 
reduced work capacity. Migraine attacks accounted for 60.3% of those who miss work 
compared to 20.4% in patients suffering from tension-type headaches. An average of 13.77 
work days are lost per year (16 days for migraine sufferers and 11 days for those with 
tension-type headache)10. 
Among secondary school students studied, in Nigeria, 76.8% of the migraine sufferers 
reported negative impact on the quality of life. This included school absenteeism, inability to 
engage in or enjoy leisure activities including sports, and inability to perform normal 
household responsibilities or chores20.  
Alcohol consumption has been reported as a significant beverage associated with triggering 
headache disorders41,42. A study carried out in Italy found that 4.9% of the participants had 
identified alcohol consumption as a trigger to migraine headaches41. Other studies have 
reported a high prevalence of smoking among patients suffering with both migraine and 
tension type headache 43,44.   
2.9 Conclusion 
 
Headache disorders pose a significant health challenge internationally and in Africa with 
prevalence rates as high as 82% in countries such as Italy. The magnitude of the problem 
has been grossly underestimated in the African continent, particularly in South Africa. The 
extent of headache disorders and their impact on the health of different populations warrant 
a closer look of this problem at a primary health care level. The influence of socio-
demographic factors on the prevalence and severity of headache cannot be ignored. 
Knowledge of the different types of headache disorders including accurate diagnosis is also 
important in determining the extent of the problem. 
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CHAPTER 3 
METHODOLOGY 
 
3.1 Aim 
 
 The aim of this study was to explore the prevalence and types of headaches seen at 
the Out-Patient Department of Dr. Yusuf Dadoo Hospital 
3.2 Objectives 
 
 To determine the prevalence of headache at the Out-Patient Department 
 To diagnose and classify headache using ICHD-II criteria 
 To describe the demographic characteristics of the patients presenting with 
headache 
 To correlate the demographic characteristics with the type of headache patients 
present with 
3.3 Study design 
 
A quantitative cross-sectional study was undertaken 
3.4 Study site 
 
The study was conducted at the OPD of Dr. Yusuf Dadoo Hospital, a level 1 hospital in the 
West Rand district, Gauteng. An average of 80-100 patients is seen, at the OPD, on a daily 
basis. The majority of this patient population are black females. There are 4 full time doctors 
and one clinical associate, who care for patients. 
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3.5 Study Period 
 
Pilot study: A pilot study was undertaken following approval from the ethics committee. It 
was conducted from 15/01/2015 to 30/01/2015. 
Study period: The main study was started following approval from the ethics committee. 
The approval was given on 07/01/2015. Data collection started on 01/02/2015 and was 
completed on 30/06/2015. On days when the researcher was on call and post call or had 
academic responsibilities to fulfil, no data collection was carried out. This, unfortunately, may 
have introduced sampling bias as some patients were inadvertently omitted from the study 
sample during these periods. There was also a two week period in the month of April where 
the researcher was on leave. The data collection period was 5 months. 
3.6 Study Population 
 
All patients who presented with headache to the OPD of Dr. Yusuf Dadoo Hospital, during 
the study period, formed the study population.  
3.7 Study Sample 
 
All patients who presented with headache to the OPD during the research period, and who 
gave consent to participate formed the study sample. This study used EPI Info STAT Calc to 
calculate the sample size. The calculation was done using the confidence interval as 95% 
and the expected sample error of 5% with a power of 80%.  In 2014 (January to March) a 
total of 86 patients were seen, whose primary complaint was headache. In a year there will, 
therefore, be 344 headache patients presenting to the OPD. The calculated sample size was 
160. All headache patients were targeted during the study period. .The sample size, at the 
end of the research, was 203 after using the inclusion criteria (see Figure 1. Chapter 4) 
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3.8 Inclusion Criteria 
 
 Patients who are 18 years and older. 
 Patients who gave consent to participate in the study 
 
3.9 Exclusion criteria 
 
 Patients who did not give consent to participate 
 Young children (less than 18 years of age) 
 Those who were critically ill and needed care in the emergency department 
 Pilot study participants 
3.10 Data collection  
 
The researcher worked in the OPD of Dr Yusuf Dadoo Hospital for 5 months. Patients who 
presented with headache were consecutively selected (i.e. all individuals who met the 
selection criteria) when they arrived at the OPD reception area for registration. There was no 
randomisation. They were greeted, welcomed and registered by the nurse who works at the 
reception of the OPD. Following measurement of their vital signs they were directed to the 
researcher’s consultation room. The researcher then explained the purpose of his study and 
the patient either chose to participate in the research or to just have their headache 
addressed as per a normal hospital consultation. Patient’s who chose to participate were 
asked to sign a consent form.  
 
The researcher then proceeded to interview the patients. This included a detailed history and 
examination. Diagnosis of headache was according to the ICHD-2 criteria (the ICHD-3 
criteria were not yet available).  At the end of the interview the researcher thanked the 
patient and managed the problem according to the 2012 EDL guidelines (see Annexure 6). 
The patient was then directed back to the reception area. From the reception area they were 
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given a return appointment, if this was necessary, and then directed to the pharmacy. 
Patients who refused to take part in the research were also managed according to the 2012 
EDL guidelines. At the end of each day the researcher collected all the questionnaires. He 
also found out the total number of patients that came to consult at the OPD on that particular 
day so that the prevalence of headache can be calculated. This was done on a daily basis 
until the end of the study period. The questionnaires were kept safely in a locked cupboard 
in the researcher’s house. The patient’s file and questionnaire were colour coded to help 
identify them and to maintain confidentiality. Data were transferred to MS Excel spreadsheet. 
The data were also password protected so that the researcher alone had access to it. 
3.11 Measuring tool/instrument 
 
A directed questionnaire was the primary tool used to collect data (see Annexure 1). It was 
written in English and the researcher administered it (interview style). The questionnaire was 
adapted from a validated questionnaire used in a previous study, in Singapore, where a 
similar study was done5. The questionnaire was reliable as it had been designed and 
directed by the Singapore Headache Society, in consultation with Neurologists who had a 
special interest in the subject of headache5. The questionnaire was modified to suite the 
African setting. The following modifications were made: 
 Race: From Chinese, Malay, Indian and others to Black, White, Coloured and Asian 
 Questions such as, “Are you satisfied with your current headache medication?” as 
our research did not focus on this area. 
 The first part (of the questionnaire) was used to collect demographic data. The second part 
was used to collect data about the type of headache the patient is presenting with.  
3.12 Pilot study 
 
A pilot study was conducted in January 2015 on ten participants, following ethics approval.  
The aim of the pilot study was to estimate the time taken to complete the questionnaire and 
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to check if there is a need for further modification of the questionnaire. After the analysis of 
the data it was found that there was no question that needed modification. The time needed 
to complete the questionnaire was 30 minutes. The data of the participants, including the 
participants themselves, were not used in the final analysis. The participants were treated 
according to the EDL guidelines after the interview 
3.13 Data analysis 
 
1.    Data entry: Data was entered into the MS-Excel spread sheet. 
2.    Data analysis: Data that has been entered into the MS- Excel spread sheet was then 
imported to the statistical software. A statistician helped with the data analysis. 
Categorical variables were analysed and the results are presented as frequencies and 
percentages. Continuous variables are presented as means and standard deviation. 
Association between socio-demographic features and types of headache was determined 
using Chi-square method for categorical data and logistic regression. The statistical 
parameter used in this study was p ≤0.05 with a CI of 95%. 
 
3.14 Ethics considerations 
 
 Confidentiality was maintained by ensuring that all questionnaires are 
anonymous. The participant’s identity was coded and a coding number was given to 
each participant’s file. The number was then entered on a separate MS Excel sheet. 
Access to this information was only via a password which only the researcher knows. 
 A participant letter and informed consent form were provided to the participant. Two 
copies were made available, one for the researcher and one for the participant. Only 
participants who agreed to participate by signing the consent form took part in the 
study. 
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 Occasionally a translator (auxiliary nurse) assisted in helping participants who could 
not speak or read English, to answer the questions. The interviewer is was fluent in 
most South African Languages, therefore a translator was rarely needed (only on two 
occasions) 
 Those who refused to participate in the study were not forced or discriminated 
against; their right to refuse was respected. 
 Permission to conduct this study was sought from the CEO of Dr Yusuf Dadoo 
hospital (See annexure 2). 
 Written permission was also sought from the West Rand District Ethics Committee. 
(See annexure 3). 
 Ethics clearance was given by the Human Research Ethics Committee (HREC) of 
the University of Witwatersrand. 
3.15 Funding of the research 
 
The cost of the research was funded by the researcher’s personal funds. 
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CHAPTER 4 
RESULTS 
 
In this section, the researcher will report the results of the data collection. Diagnosis of 
headache, prevalence, the demographic characteristics of the participants and how these 
correlate with headache diagnosis, will be presented. 
                               
             206 participants approached 
 
 
               
            3 participants refused to sign consent 
            and were not included in the research   
 
 
            203 participants signed the consent form and  
                  became part of the study group  
 
Figure 1.  Selection of the patients 
 
Two hundred and three participants made up the study population. The response rate was 
98.5%. 
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4.1 Prevalence of headache in the study centre 
 
The total number of patients seen in OPD during the study period was 4408. The one day 
prevalence of headache was calculated to be 4.7% (206/4408 X 100). This number includes 
patients who refused to participate in the study. 
4.2 Headache classification using ICHD-II criteria 
 
Table 4.1 Types of headache 
  
HEADACHE TYPE NUMBER OF 
PARTICIPANT 
N=203 
PERCENTAGES 
Type of headache N=203  
Primary headache 142 69.95 
Secondary headache 61 30.05 
PRIMARY HEADACHE N=142  
Migraine 41 28.87 
Tension Headache 77 54.23 
Mixed 
headache(tension/migraine) 
24 16.90 
   
SECONDARY HEADACHE N= 61  
   
Cause of Secondary 
Headache 
  
Head and/or neck trauma 9 14.75 
Non-vascular intracranial 
disorder 
6 9.84 
Substance or its withdrawal 4 6.56 
Infection 21 34.43 
Disorder of homeostasis 8 13.11 
Disorder of cranium, neck, 
eyes, ears, nose, sinuses, 
teeth, mouth, or other facial 
or cranial structures 
13 21.31 
 
Seventy percent of the participants had primary headache and 54.23% of them had tension 
headache. Infections were the commonest causes of secondary headache and they were 
seen in 34.43% of the secondary headache participants.  
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4.3 Socio demographic characteristics of the participants 
 
Table 4.2  Demographic characteristics of the participants 
 
Demographic Variables Number of 
participants 
(N=203) 
Percentages Mean +/-  SD 
AGE GROUP (YEARS)   48.09  +/- 15.29 
Youth (18-24 yrs) 15 7.39 
Young adults (25-39 yrs) 50 24.63 
Middle aged Adults (40-64 yrs) 108 53.20 
Aged (≥65yrs) 30 14.78 
GENDER    
Female 147 72.41 
Male 56 27.59 
ETHNIC GROUP   
Black  130 64.04 
White 66 32.51 
Coloured 6 2.96 
Asian 1 0.49 
EDUCATIONAL LEVEL   
No Schooling 10 4.93 
Primary School 31 15.27 
High School 134 66.01 
Post High School qualification 28 13.79 
MARITAL STATUS   
Single 56 27.59 
Married 60 29.56 
Co-habiting 35 17.24 
Divorced 28 13.79 
Widowed 24 11.82 
MONTHLY INCOME   
No income 33 16.26 
<R1000 5 2.46 
R1000-R5000 134 66.00 
R5001-R10000 18 8.87 
>R10000 13 6.40 
EMPLOYMENT STATUS    
Unemployed 107 52.71 
Employed 86 42.36 
Part-time Employed 10 4.93 
TYPES OF UNEMPLOYMENT N=107  
No job 50 46.73 
Pensioner 48 44.86 
Student 9 8.41 
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The age range of the participants was between 18 and 88 years with a mean age of 48 
years. Fifty three percent (108/203) of the participants were middle aged adults. Black 
married females with a high school qualification made up the majority of the participants. 
Sixty six percent of the participants earned a monthly salary between R1000-R5000. Fifty 
three of the participants were unemployed (pensioners or no job). 
Table 4.3 Social characteristics of the participants 
 
Demographic Variables Number of participants 
N=203 
Percentages 
% 
ALCOHOL USE   
Participants who used alcohol 55 27.09 
Participants who did not use alcohol 148 72.91 
ALCOHOL CONSUMPTION IN 
NUMBER OF GLASSES   
N=55  
1 to 5 36 65.45 
6 to 10 15 27.27 
>10 4 7.27 
PERIOD WHEN ALCOHOL WAS 
CONSUMED 
N=55  
Weekends/special occasions 54 98.18 
Week days 1 1.82 
RECREATIONAL DRUG USE N=3  
Participants who used recreational 
drugs 
3 100 
USE OF  CIGARETTES N=203  
Participants who smoked cigarettes 52 25.62 
Participants who did not smoked 
cigarettes 
151 74.38 
NUMBER OF PACK YEARS FOR 
PARTICIPANTS WHO SMOKED 
N=52  
1-10 23 40.35 
11-20 20 35.09 
21-30 8 14.04 
31-40 5 8.77 
>40 1 1.75 
 
Twenty seven percent (55/203) of the study population used alcohol. They drank 1-5 glasses 
at a time and used it more frequently during weekends while 25.62% (52/203) smoked 
cigarettes, with a pack year history of 1-10 years. 
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4.4 Characteristics related to headache 
 
Table 4.4  Characteristics related to headache  
 
Variables Number of participants 
N=203 
Percentages (%) 
Headache duration   
<1 year 76 37.44 
1-5 years 40 19.70 
>5 years 87 42.86 
Number of days per month   
1 day 17 8.37 
2-4 days 60 29.56 
5-10 days 39 19.21 
11-15 days 35 17.24 
>15 days 52 25.61 
Severity of headache   
Mild (1-4) 10 4.93 
Moderate (5-7) 85 41.87 
Severe (8-10) 108 53.20 
Inactivity caused by 
headache 
  
No of participants who were  
unable to work 
94 46.31 
No of participants who were  
able to work 
109 53.69 
Use of Headache 
Medication 
  
Participants who used 
medication for headache 
168 82.76 
Participants who did not  use 
medication for headache 
35 17.24 
Overusing of  Pain 
Medication for acute 
headache 
  
Participants who overused 
medication 
60 29.56  
Participants who  did not 
overuse medication 
143 70.44 
 
Forty three percent (87/203) of the participants had headache for more than 5 years with a 
frequency of two to four days per month. Fifty three percent reported that the headache was 
severe. Fifty three percent of the participants could perform their daily activities despite 
suffering from headache. Eighty three percent reported that they used headache medication 
(168/203). Thirty percent reported that they overused pain medication.  
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4.5 Association between headache types and social characteristics of the participants 
 
 
Pearson chi2 = 0.2573925    p-value = 0.612 
Figure 2. Alcohol use and Headache types 
 
Despite this result not being statistically significant, those who used alcohol were 2 times 
more likely to have primary headache than secondary headache.  
 
Pearson chi2 = 0.8479143   p-value = 0.357  
Figure 3.  Cigarette smoking and Headache type 
 
Cigarette smokers were 3 times more likely to have primary headache than secondary 
headache. This result is, however, not statistically significant.  
 
37 
18 
Alcohol use 
Primary Headache Secondary Headache 
39 
13 
Cigarette smoking 
Primary Headache Secondary Headache 
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4.6 Association between Socio-demographic features of the participants vs. sub-
divisions of primary headache 
 
 
Pearson chi2 = 13.2660   p-value = 0.010 
Figure 4. Employment status vs. sub-divisions of primary headache  
 
There was a statistically significant relationship between employment status and sub-
divisions of primary headache. More unemployed participants suffered from Tension 
headache compared to those in the employed category [62/76, 82% vs. 25/59, 58%]. 
Participants who were unemployed were three times more likely to suffer from Tension 
headache compared to those who were employed and the confidence interval was narrow. 
[OR: 3.2, p: 0.010, 95% CI: 1.50-7.08]. 
 
 
 
 
 
Migraine 
headache 
Tension 
headache 
42% 
58% 
29% 
72% 
18% 
82% 
Employed Part time employed Unemployed 
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4.7 Socio-demographic features vs. sub-division of secondary headache 
 
Pearson chi2 = 21.1403   p-value = 0.000 
Figure 5. Age category vs. sub-division of secondary headache  
 
There was a statistically significant relationship between types of secondary headache and 
age category. Non infectious headache was seen more frequently in aged adults when 
compared to the youth [7/7, 100% vs. 2/8, 25%]. Aged adults were 16 times more likely to 
suffer from non-infectious headache compared to the youth, however the 95% confidence 
interval was very wide [OR: 15.6, p: 0.004, CI: 2.42-100.68]. 
 
 
 
 
 
 
25% 
33% 
84% 
100% 
75% 
67% 
16% 
0% 
0% 
20% 
40% 
60% 
80% 
100% 
120% 
Youth Young adult Middle aged adults Aged adults 
Non infectious Infectious 
25 
 
 
Pearson chi2 = 8.7157   p-value = 0.013  
Figure 6. Ethnic groups vs. sub-division of secondary headache  
 
There was a statistically significant relationship between sub-divisions of secondary 
headache and ethnic group. Non-infectious headaches were seen more frequently in white 
participants when compared to black participants [16/17, 94% vs 22/41, 54%]. White 
participants were 14 times more likely to suffer from non infectious secondary headaches 
compared to black participants, however the 95% confidence interval was very wide [OR: 
13.8, p: 0.015, CI: 1.67-114.14 ]. 
There was no statistically significant relationship between headache types, sub-divisions of 
primary headache and sub-divisions of secondary headaches and the following variables: 
Gender, educational level, marital status, and monthly income. There was no statistically 
significant relationship between headache types, sub-divisions of primary headache and age 
and ethnic group and between headache types and sub-divisions of secondary headaches 
and employment (i.e. No other comparisons yielded statistically significant results). 
Validity and reliability of results 
There was consistency in the methodology and findings of the research. 
Non -infectious headache Infectious Headache 
54% 
46% 
67% 
33% 
94% 
6% 
Black Coloured White 
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CHAPTER 5 
 DISCUSSION 
5.1 Introduction 
 
This section of the report discusses the results of the study and compares them to other 
studies that were carried out in other parts of the world. 
5.2 Methodology 
 
A larger study sample would have been desirable, in this study, but time constraints 
prevented its realisation. A cross-sectional study was carried out in order to have a snapshot 
of headache prevalence, in this hospital. The researcher was happy with the response rate 
(98.5%). The study design was suitable for the objectives of the study. 
5.3 Prevalence of headache 
 
This study determined the prevalence of headache among adults aged 18 years and above 
at the OPD of Dr. Yusuf Dadoo Hospital.  Such a study had never been done in this 
institution and there was also a paucity of these kinds of studies at a primary health care 
level in South Africa and Sub-Saharan Africa.  
The prevalence of headache disorders was found to be 4.7% among those attending the 
OPD of Dr. Yusuf Dadoo Hospital. Most studies report a 1 year prevalence or lifetime 
prevalence of headache, in contrast to the 1 day prevalence used in this study. One year 
prevalence and life time prevalence studies tend to have higher percentages. In a study 
conducted in India the 1 day prevalence was low (5.9%). This number is comparable to the 
current study findings.   However, the same study had a higher (62%) 1 year prevalence 22. 
Headache centres have higher prevalence rates by virtue of the fact that they are 
specialized units23. This is not the case with primary health care centres as most of the 
patients who present for consultation are undifferentiated. In a primary health care facility in 
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Brazil, the 1 day prevalence of headache disorders was 10.4%24. Population studies, in 
contrast, report higher prevalence rates of headache disorders with some studies reporting 
percentages as high as 82.5%22,25,26. These numbers suggest that a lot of headache 
sufferers do not present to health care facilities for help, because population studies include 
headache sufferers who have not necessarily presented to a health care facility for help. 
This may be the case with the population that Dr. Yusuf Dadoo Hospital serves.   
5.4 Types of headache 
 
The ICHD-II diagnostic criteria were used together with acceptable study methods. In 2013 
the ICHD-III beta version was published by the International Headache Society21. At the time 
of writing the protocol, the researcher had not found any related studies that have used this 
new guideline.  
Most of the participants suffered from primary headaches (69.95%). This is consistent with 
findings from other prevalence studies conducted globally (61.6%)27. A cross-sectional study 
carried out in Zambia found the prevalence of primary headache to be 61.6%27. A similar 
study which was carried out in India reported the 1 year prevalence to be 63.9%, confirming 
the pervasiveness of primary headache in the general population28. Steiner et.al conducted a 
large study in Europe. Their results suggest that primary headache disorders are more 
widespread with a life time prevalence of 91.3% and a one year prevalence of 78.6%29. 
Although some of these studies27 were carried out in the general population and not in a 
health care facility the numbers do confirm that primary headache disorders are indeed 
common.  
Tension type headache and migraine are the commonest primary headache disorders11. In 
this study TTH was the commonest primary headache disorder seen (54%). In Zambia 
Mbewe et. al found the prevalence rate between migraine and TTH to be  equal,  22.9% and 
22.8% respectively27. However, in India, Kulkarni et. al reported a higher prevalence of TTH 
28 
 
(35.1 %) compared to migraine (25.2%), among the study participants28. Steiner et al. also 
found TTH to be more prevalent in their study29. Dowson concurs with these observations: 
“TTH is a ubiquitous condition that is highly prevalent in the community and has a large 
impact on people’s lives and society as a whole”32. Even though, in this study, the observed 
difference between TTH and migraine (54% vs. 29%) was greater, the results confirm a 
similar observation in other studies11,17. 
The prevalence of secondary headache disorders was surprisingly high (30.05%). This may 
be due to the fact that this study was conducted in a hospital setting and not a primary care 
clinic setting. A study conducted in Spain reported a prevalence of secondary headache 
disorders to be 16%. This study was carried out on a population of the elderly (≥65 years) in 
a headache specialist unit of a tertiary hospital30. The prevalence in this study may be 
slightly lower than that observed at the OPD of Dr. Yusuf Dadoo hospital because it focused 
on a single age group. Onwuekwe et.al observed a higher prevalence (29% males, and 23% 
females) among health workers in a Nigerian hospital31. In both studies discussed above 
secondary headache disorders have a lower prevalence rate when compared to primary 
headache disorders. This is the same case in Dr. Yusuf Dadoo hospital.  
5.5 Demographic characteristics of the participants 
5.5.1 Age 
 
Adults between the ages of 40-64 (mean 48.09,+/- 15.29) years presented more frequently. 
In Zambia those between the ages of 18-29 years (34%) made up the majority of headache 
sufferers27 while the mean age in headache sufferers from various European nations was 
between 40-50 years29.  The age findings of the European study are similar to those 
observed in this study. Other studies, like the Zambia study, tend to report greater 
prevalence in younger participants 22,28,31,33. Most of those who consult at the OPD of DYDH 
are elderly people suffering from various chronic diseases. This is possibly the reason why 
the researcher observed a greater number of those between the ages of 40-64 years. 
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5.5.2 Gender 
 
Female participants suffered more than male participants (72% vs. 28%). This is consistent 
with other prevalence studies7,8,10,14. A study looking at the prevalence and burden of 
headache in Nepal reported a higher rate amongst females33. Arslantas et.al also reported a 
higher prevalence of headache among females, with an accompanying significant impact on 
quality of life34. Autret et. al also had a similar observation with an increase in psychosocial 
challenges among females compared to males35. While this study did not directly observe 
the related psychosocial issues accompanying headache disorders, it is possible that 
females attending the OPD of DYDH are significantly impacted by this pain. This does not 
mean that men should be ignored. They also can be significantly impacted, especially when 
suffering from Migraine headaches35.        
5.5.3 Ethnic group 
 
The majority of the people who live in the West Rand District are blacks36. Since DYDH is a 
public hospital, the patients seen are predominantly blacks and this study reflects this (64%). 
A study conducted in the United States of America (USA) reported a greater prevalence of 
headache disorders among Caucasians. However, Caucasians were the majority of 
respondents in the study37. With the exception of the USA18,37 not many studies have 
focused on Ethnicity as having a significant relationship with the prevalence of headache 
disorders.   
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5.5.4 Level of education 
 
Most of the participants in this study attained a high school level of education (66%). This 
number is comparable to a study carried out in Italy (in a headache centre) where most of 
the participants had a low to moderate level of education38. A study looking at the 
epidemiology of headache in Zambia found the majority of participants to have attained a 
secondary level of education (54%) while the rest of the participants had attained a Primary 
(25%) or Higher (21%) level of education39. At DYDH 15% had a primary school qualification 
and only 14% had a post high school qualification.  In their study looking at how headache 
impacted the quality of life among adults, Arslantas  et al found that most (78%) of the 
headache sufferers had a Secondary or lower educational level34. 
 Another study, carried out in France, found the majority of participants who had consulted in 
various headache specialist centres to have left school between the ages of 16 to 19 
years35. This is the age where most people are in high school. A prevalence study in India 
reported a similar observation among headache sufferers. The majority of the study 
participants had a high/middle school qualification while fewer participants had a primary or 
professional qualification28.  This is in contrast to another prevalence study carried out in 
India where the majority of headache sufferers were found to be illiterate22. There are not 
many studies which report this trend. Only 5% of the participants at the OPD of DYDH had 
not attained any level of education.  
In 2013 Smitherman et al. published a study which found the majority of headache sufferers, 
in the USA, to have attained a low level of education (high school and lower)40. The findings 
in this study (with regard to level of education) are therefore consistent with most of the 
prevalence studies carried out in different countries (both low income and high income 
countries). 
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5.5.5 Marital status 
 
Participants who reported to be married were slightly more than those who are single (30% 
vs. 28%). A study looking at anger and distress among headache suffers reported a higher 
prevalence among the married compared to those who are single, divorced or widowed38. 
Gururaj et al. reported a higher prevalence of headache sufferers among the married (72%) 
compared to the non-married22. In Turkey a headache prevalence study also reported a high 
percentage (75%) of married participants to be suffering with headache34. In both rural and 
urban participants of headache sufferers Mbewe et al. found most (51%) of them to be 
married compared to the unmarried. These studies have significantly higher percentages of 
headache sufferers who are married compared to the OPD of DYDH. It is, however, possible 
that in South Africa there is a higher percentage of those who are co-habiting, thus 
decreasing the percentage of married individuals who suffer with headache.  
A study done in Ethiopia reported a different observation to the ones reported in the studies 
discussed above. They reported a higher proportion of headache sufferers among those who 
are widowed and divorced10. The combined percentage among the widowed and divorced in 
the OPD of DYDH is 26%. Therefore, despite a slightly higher number of married 
participants complaining of headache, the OPD of DYDH seems to have comparable 
proportions of headache sufferers in the marital status category.   
5.5.6 Monthly income and employment status 
 
Unemployed participants presented more frequently and those who are employed earned a 
low income salary (R1000-R5000). A headache prevalence study carried out in America, 
comparing gender differences and other demographic factors associated with headache, 
reported percentages within the same range (of headache sufferers) among different income 
classes37. In Zambia the unemployed and unskilled participants together made up the 
majority of headache sufferers (70%)39. A study carried out in Turkey, looking at the 
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prevalence of headache and its effects on adults, found that more of the participants were 
employed (60%) compared to the unemployed34. This is in contrast to another study carried 
out in Turkey that reported a 27% unemployment prevalence among the participants26. The 
difference between observations made in the OPD of DYDH, other African countries and 
American/European countries may be related to economic factors in the respective 
countries. In India more employed individuals suffered from primary headache disorders 
compared to unemployed individuals28. Another study in India also reported a lower 
prevalence of unemployed participants (7%) suffering from headache disorders22. This is a 
unique observation in a country known to have more low income and unemployed people. 
While our study reported a 5% prevalence of participants who are part-time employed other 
studies did not use this terminology.  
5.6 Social features of the participants 
 
Alcohol consumption is an important and frequent dietary cause and trigger of primary 
headaches 41,42. Twenty seven percent of the OPD participants reported use of alcohol and 
only one patient used on week days. A study looking at factors associated with primary 
headache disorders found that 26% of migraine headache sufferers and 35% of tension 
headache sufferers consumed “light alcohol beverages”. Ten percent of migraine headache 
sufferers and 15% of tension headache sufferers consumed “strong alcoholic beverages”43. 
Our study did not separate participants into users of light and strong alcohol beverages. 
Only three participants who presented to the OPD used recreational drugs. There are not 
many contemporary studies that have looked at the prevalence of headache among 
recreational drug users. In 1991 Dhuna et al. reviewed records of 21 patients who were 
admitted for cocaine related headache. Fifteen patients had headaches with features of 
migraine. “All  the patients were habitual cocaine users”49. Unfortunately we did not look at 
the frequency of recreational drug use. An important observation, however, was that 6.56% 
of secondary headache disorders was due to a “substance or its withdrawal”.  
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Twenty six percent of the participants smoked cigarettes. Lebedeva et al. reported that 26% 
of migraine sufferers and 35% of tension headache sufferers were current smokers. 
However, they did not specify the level of smoking in pack years43. Orhurhu et al. reported a 
high prevalence of smoking among those suffering from chronic diseases, including 
headache disorders44. The prevalence of smoking in headache sufferers who presented to 
the OPD of DYDH should therefore not be ignored. 
5.7 Characteristics related to headache 
 
Forty three percent of the patients had suffered with headaches for more than 5 years while 
20% had headache disorders for no more than five years (1-5 years). Thirty percent had 
headaches for 2-4 days/month while 26% had headaches for more than 15 days/month. In 
Zambia Mbewe et al. reported a duration of 3.4 days a month27.  In Nepal Manandhar et al. 
reported a mean duration of 3.8 (+/-6.2 SD) days per month, which was higher among 
females (4.3 +/- 6.9 SD)33. “A survey conducted in seven European countries and Russia 
revealed that headache is one of the most frequent types of everyday pain”32.  Those 
attending the OPD of DYDH seem to be impacted by headache more frequently.  
 
In a Nigerian study, among health workers, Onwuekwe et al. found the highest frequency to 
be between 6-10 days. They, however, used frequency in the past 6 months. They also 
found that the majority (57%) of the participants experience the headache at no specific time 
of the day31.  In Turkey the headache days per month were reported to be 6.3 days (± 6 SD) 
among the females and 6.0 days (± 6 SD)26. A study done in Pakistan found that 49% of the 
participants (male and female) had suffered from headache disorders for over five years and 
39% of the participants experience the problem for more than 14 days a month44.  Our study 
findings are therefore consistent with other prevalence studies with regard to the burden of 
headache as expressed in terms of headache duration. 
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Inactivity caused by headache expresses headache severity and our study found that 46% 
of the participants could not work when experiencing a headache attack. Fifty three percent 
of the participants felt that their headache was severe. This finding is not unique to the OPD 
of DYDH. In Austria  a study involving eight headache centres reported a high percentage 
(62%) of patients  who lost at least 11 days, as a result of headache, 3 months prior to the 
study23.   
 
An Italian study found that those who had suffered with headache for more than 15 days a 
month were impacted the most. They lost more days from work25. Interestingly though, 
among health workers who participated in a headache study, in Nigeria, most did not feel 
that the headache impacted their work. Only 2 percent believed that their headache disorder 
was severe and 10% felt that the headache was severe enough to impact on their daily 
activities. Seven percent had been absent from work as a result of the headache problem31.  
 
Autret et al. found a significant number of their study participants to have their physical 
function, general health perception, social function and mental health significantly impacted 
by headache disorders35. Mbewe et al. estimated the GDP loss to be up to 2% as a result of 
the burden of headache on Zambia’s population27. It is a possibility, in South Africa, that 
there is a significant impact on the economy as a result of the burden of headache on this 
population.  
   
A large number (29%) of the study participants in our study overused headache medication. 
This figure is three times higher than that reported by the World health organization11. In 
Nepal those who were classified as overusing headache medication had their quality of life 
profoundly impacted33. In India the prevalence of medication overuse was only 1.2%28 with a 
similar number (1.3%) reported in Turkey26. A multicentre study in Austria had percentages 
that are a little closer to those observed in our study (16%)23. The higher numbers observed 
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in our study may be suggestive of sub-optimal management of headache disorders in the 
OPD of DYDH. 
5.8 Association of socio-demographic features and types of headache 
 
This study found that those who used alcohol were 2 times more likely to have primary 
headache than secondary headache even though this result was not statistically significant. 
Panconesi et al. found that habitual alcohol consumption triggers Migraine without aura in 
15% of their participants41. They however did not find an association between habitual 
alcohol consumption and tension headache. This is in contrast to Lebedeva et al. who found 
that consumption of “light” alcohol was associated with Tension type headache43. Our study 
did not differentiate Migraine and Tension headache when comparing associations between 
alcohol consumption and headache types. A review study reported that, in most countries, 
up to a third of migraine patients report alcohol consumption as a trigger of their headache. 
Many of these studies were, however, retrospective studies42. Unfortunately our study did 
not differentiate between strong and weak alcoholic drinks. 
 
Despite this result not being statistically significant, this study found that cigarette smokers 
were 3 times more likely to have primary headache than secondary headache. Orhurhu et al 
reported a 21% prevalence of chronic headache (primary headache) as a result of chronic 
smoking44. This number is comparable to our study (19%). Sarker et al. found that use of 
cigarettes (both smoking [24.6%] and smokeless [15.9%]) is associated with migraine 
headache45.  
In this study participants who are unemployed were 3 times more likely to suffer from 
Tension headache compared to those who are employed ( p-0.010, CI: 1.50-7.08) Twenty 
five percent of participants in Stang et al.’s study were headache sufferers who were 
unemployed. Although their study did not discriminate between headache types they found 
that headache sufferers were most likely to be unemployed46. In contrast to our study 
36 
 
Arslantas et al. do not report employment status as a statistically significant cause of primary 
headache or any headache type34. 
This study found that the elderly (≥ 65 years) were 16 times more likely to suffer from non-
infectious secondary headache compared to youth (18-24 years) (p-0.004, CI:2.42-100.68). 
A study conducted in Iran found that the prevalence of secondary headache increased with 
age in their participants47. They, however, also found that infectious causes of secondary 
headache (meningitis and sinusitis) were more prevalent in the younger age groups. They 
reported the overall prevalence of Secondary headache as 20.1%. In their study looking at 
the prevalence of headache in the elderly, Lisotto et al. reported a higher prevalence of 
headache in participants who were older than 65 years48. However, they also found that non-
infectious causes of secondary headache were more prevalent in this age group. Ruiz et al. 
also found that Primary headaches are more prevalent in the elderly and confirmed that non-
infectious secondary headaches account for the majority of secondary headache complaints 
in this age group30. 
Although our study found a statistically significant relationship between ethnicity and 
secondary headache types, no studies were found that directly address this association. The 
significantly higher number of blacks who presented to the OPD may have influenced our 
result. Unfortunately our study also did not demonstrate a statistically significant relationship 
between headache types, sub-divisions of primary headache and sub-divisions of secondary 
headaches and the following variables: gender, educational level, marital status, and 
monthly income. In addition to this, there was no statistically significant relationship between 
headache types, sub-divisions of primary headache and age, ethnic group and between 
headache types and sub-divisions of secondary headaches and employment. In particular, it 
was surprising that gender did not yield statistically significant associations with certain 
headache types (e.g. primary headache disorders such as Tension headache, as discussed 
in the Literature review section). 
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Limitations 
 
 Time constraints could not allow for a larger sample size. It is possible that with a 
longer period of data collection certain variables could have yielded statistically 
significant associations. The inability of the researcher to collect data on days when 
he was on call, post call or attending to other academic responsibilities could have 
resulted in sampling bias (omission bias) and played a role in the outcome of results. 
 The type of study carried out (cross-sectional study) places more focus on 
prevalence and thus weakens the strength of the subject studied. 
 The study was carried out in a hospital setting, where there is a possibility that a 
certain group of the population will present more frequently than another group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38 
 
CHAPTER 6  
CONCLUSION AND RECOMMENDATIONS 
 
The study objectives were met and the findings were comparable with other studies carried 
out in other parts of the world. Headache disorders are a significant challenge that afflicts 
patients who present to the OPD of Dr. Yusuf Dadoo Hospital. Primary headache disorders 
are the commonest types of headache seen but there are also a significant number of those 
who suffer with Secondary headache disorders. Tension type headache is the commonest 
sub-division of Primary headache disorders and this needs to be noted as it is not a disorder 
that is difficult to manage.  Middle aged adults suffered more than those in other age groups. 
It is possible that this observation was influenced by the type of patients who commonly 
present to the OPD of Dr. Yusuf Dadoo Hospital (those with some type of chronic disorder). 
This same explanation may apply to the reason why Black adults presented more commonly 
than other ethnic groups (they make up the majority of patients who attend the hospital). As 
observed in other studies, carried out globally, unemployed and low income level female 
participants made up the majority of headache sufferers. While a statistically significant 
association was not observed between alcohol consumption, cigarette smoking and 
headache disorders, the fact that more of those who used these substances suffered with 
headache disorders should not be ignored. We found a statistically significant relationship 
between employment status and sub-division of primary headache disorders; age category 
and sub-division of secondary headache and ethnic group and sub-division of secondary 
headache.  
Therefore the following recommendations are made: 
 Guidelines that specifically address the management of headache disorders at 
district hospitals, in South Africa, need to be updated and improved, in order to 
assist those working in such centres. 
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 Primary health care physicians need to be aware of the burden of headache 
disorders among those who consult with them, and more should be done  by 
national authorities to train health workers in the proper diagnosis and management 
of headache disorders.  
 The results suggest that there is a possibility that many headache sufferers are 
economically impacted (46.31% stated that they were unable to work as a result of 
suffering from headache disorders) by this disorder (women in particular), therefore 
increased efforts to decrease the level of morbidity among those affected need to be 
made in order to curb the socio-economic impact headache disorders have on those 
afflicted by them.    
 Health education should be given to patients, about the effects of alcohol and 
smoking in precipitating headache disorders. 
 Further studies should be embarked on with the aim of closely looking at the 
psychosocial impact headache disorders have on patients, as a high number of 
headache sufferers are not only unable to work but also tend to overuse headache 
medication.  
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Annexure 1 – Questionnaire 
 
Diagnosis and prevalence of headache at the out-patient department of Dr. Yusuf 
Dadoo Hospital. 
Part I: Socio-demographic features 
1. Code number for the patient? ……………………………………… 
2. What is your age in Years? ……………………………………... 
3. What is your Gender?    
☐ Male              ☐ Female 
4. Which ethnic group do you belong to? 
☐     White  ☐ Black   
☐     Coloured  ☐ Asian  
5. What is your educational level?  
☐ No schooling ☐ Pre-school ☐ Primary School ☐ High School     
☐        Diploma         ☐Post Higher Diploma                 ☐ Bachelors Degree  
☐        Honours Degree   ☐Higher Degree (Masters/PhD) ☐Other 
6.      What is your marital status?    
☐ Single  ☐ Married  
☐ Co-habiting ☐ Divorced  ☐ Widowed 
7. What is your employment Status?    
☐ Student ☐ Pensioner  
☐ Unemployed  ☐ Employed    
☐ Part-time employment 
8. a) How much monthly income do you receive?  
☐ No monthly income 
☐  <R1000/Month                        ☐ R1000-R5000/Month  
☐ R5000-R10000/Month  ☐ >R10000/Month 
 b) Where do you receive this income from?  
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☐ Child support grant     ☐ Disability grant   
☐ Pensioner  ☐ Depend on family member   
9. a) Do you use alcohol?    
☐ Yes   ☐ No 
 b) If yes, how much do you drink ………………………… 
            c) When do you drink? ……………………………………. 
            d) If yes, how often:    
☐ On weekends/special occasions   ☐ Once a week   
☐ Twice a week                                      ☐ Three times a week 
☐ Daily  
10. Do you use recreational drugs like dagga, marijuana, and heroine?  
☐  Yes    ☐ No 
11. Do you smoke cigarettes?  
 ☐ Yes    ☐ No 
 If yes, how many cigarettes do you smoke per day and for how many years?  
 ………………………………………………………………………………………… 
Part II: Diagnosis and Type of headache (to be completed by the researcher) 
12.  How long has it been since you have started having headaches?   
☐ Less than 1 year  ☐ Between 1–5 years  ☐ More than 5 years 
13. How many days in a month do you experience headaches? 
 ☐1 day ☐2-4 days ☐5-10 days ☐10-15 days ☐>15 days 
14.  When you have a headache, have you been inactive for at least 1 day over the past 
3 months?  ☐ Yes  ☐ No 
15.  Is the patient presenting with migraine?  ☐   Yes  ☐   No 
16.  Is the patient presenting with a tension type headache?  ☐   Yes  ☐   No 
17.  Is the patient presenting with a cluster headache or other trigeminal autonomic 
headache?  ☐   Yes  ☐   No 
18.       Is the patient presenting with other trigeminal autonomic headaches? 
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☐   Yes  ☐   No 
19.  Is the patient presenting with a secondary headache?   
☐   Yes  ☐   No 
20. If yes what is the most likely cause? ----------------------------------------------------------- 
21. Is the patient taking medication for headache? ☐   Yes  ☐   No  
22.  Is the patient overusing acute pain medication?   ☐   Yes  ☐   No  
(≥ 15 days per month for simple analgesics or ≥ 10 days for ergotamines, triptans, opioids or 
combination medication)  
23. How painful was the most painful headache the patient had in the past year?  
On the scale 0 to 10 (with 0 being no pain and 10 being the worst pain imaginable) 
1  2  3  4  5  6  7  8  9  10 
Thank you for your participation  
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Annexure 2 – Hospital CEO’s permission letter 
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Annexure 3 – HREC Clearance Certificate
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Annexure 4 – Permission letter from the West Rand Health District Director
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Annexure 5 – Participant’s information sheet and consent form 
 
HREC protocol approval number:………………….. 
Hello 
My name is Dr. Moshe Magethi I am a Registrar in Family Medicine studying at the 
University of the Witwatersrand. I am conducting a research project that will be assessing 
the “Diagnosis and Prevalence of Headache at the Out-Patient Department of Dr Yusuf 
Dadoo Hospital”, as part of the fulfilment for my Masters Degree. You are invited to volunteer 
to participate in this research study. Your participation in this study is voluntary. Before 
agreeing to participate in this study, it is important that you read and understand the 
following explanation of the purpose of the study, benefits, risks, discomfort, and precautions 
as well as your right to withdraw from the study at any time. This information leaflet is to help 
you to decide if you would like to participate. You should fully understand what is involved 
before you agree to take part in this study. Should you have any questions, which are not 
fully explained in this leaflet, do not hesitate to ask, me, the study doctor. If you decide to 
take part in this study, you will be asked to sign this document demonstrating your 
understanding of the study. You will be given a copy of this document to keep.  
Purpose of the study: 
The study will be assessing headaches that adult patients present with at the outpatient 
department of Dr. Yusuf Dadoo hospital. There is little knowledge about this subject in 
developing countries like South Africa, in particular. As a result many patients who have this 
problem are under diagnosed and mismanaged. This study will help increase knowledge 
about the magnitude of the problem at district level. It will also assist in increasing diagnosis 
and correct management of those who suffer from various headache disorders.  
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Procedure: 
The researcher will conduct an interview/ ask you questions about your complaint, from a 
questionnaire that is specifically designed for the research. He will complete the 
questionnaire according to your response to the questions. This should take at most 15 
minutes to answer. The study doctor will examine you as part of the normal consultation. 
The study doctor will also provide you with the appropriate treatment, according to the EDL 
guidelines.  
Risks and benefits: 
There are no foreseeable risks associated with your participation in the study. You will not 
receive any remuneration for participating in the study. The relevant education and/or 
referral for treatment will be given to you at this visit, as per South African standard of care. 
Confidentiality and Data storage: 
All the information that you provide will be kept confidential. The study doctor will not be 
required to record your name or date of birth on the questionnaire and you will not be directly 
identified in the research report. The questionnaire will be coded. Your name and/or date of 
birth will not appear on any data collection tool used in the study. 
Are there any restrictions concerning my participation in this study? 
 If you are younger than 18 years of age, you cannot participate in the study 
 If you are critically ill you cannot participate in the study  
Rights as a participant in this study: 
 Your participation in this study is entirely voluntary and you can decline to participate, 
or stop at any time, without stating any reason. 
Withdrawal: 
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 Your withdrawal will not affect your access to other medical care. 
Research results: 
A research report will be submitted to the University of the Witwatersrand. You may request 
a copy of the report or any other feedback and information that you may require. Kindly 
contact me on e-mail: mmagethi@gmail.com or 0839502920 
Complaints: 
The HUMAN RESEARCH ETHICS COMMITTEE (MEDICAL) of the University of the 
Witwatersrand has approved this study. Ref No…………………………… 
If you have concerns or complaints about the conduct of this study please contact the Wits 
Research Office at 011 717 1234 
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                                                   INFORMED CONSENT 
                                 UNIVERSITY OF THE WITWATERSRAND 
 I hereby confirm that I have been informed by the study doctor, Dr. Moshe Magethi, 
about the nature, conduct, benefits and risks of the study: Diagnosis and 
prevalence of headache at the Out-Patient Department of Dr. Yusuf Dadoo 
Hospital      
  Protocol number:………………. 
 I have also received, read, and understood the above information (Participant 
Information Leaflet and Informed Consent) regarding the study. 
 I am aware that the results of the study, including personal details regarding my sex, 
age, date of birth, initials and diagnosis will be anonymously processed into a study 
report. 
 In view of the requirements of research, I agree that the data collected during this 
study can be processed in a computerised system by the study doctor. 
 I may, at any stage, without prejudice, withdraw my consent and participation in the 
study. 
 I have had sufficient opportunity to ask questions and (of my own free will) declare 
myself prepared to participate in the study. 
 
Participant:        Name:………………………………… 
                             Signature/ Thumbprint: 
                             Date and Time:……………………..... 
I, Dr. Moshe Magethi, herewith confirm that the above participant has been fully informed 
about the nature, conduct and risks of the above study. 
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Study doctor:   Name:………………………………… 
                             Signature/ Thumbprint: 
                             Date and Time:……………………..... 
 
 
Translator/ Other person explaining informed consent form……….(Designation): 
Name…………………………….. 
Signature……………………….. 
Date/ Time………… 
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Annexure 6 – Types of headache 
 
Below is a brief summary of headache classification8: 
Primary Headaches 
1. Migraine 
2. Tension type headache 
3. Cluster type and other trigeminal autonomic cephalalgias 
4. Other primary headaches 
Secondary Headaches 
1. Headache attributed to head and/or neck trauma 
2. Headache attributed to cranial or cervical vascular disorders 
3. Headache attributed to non-vascular intracranial disorder 
4. Headache attributed to a substance or its withdrawal 
5. Headache attributed to infection 
6. Headache attributed to disorder of homoeostasis 
7. Headache or facial pain attributed to disorder of cranium, neck, eyes, ears, nose, 
sinuses, teeth, mouth, or other facial or cranial structures 
8. Headache attributed to psychiatric disorder 
Cranial Neuralgias, central and primary facial pain and other headaches 
1. Cranial Neuralgias and central causes of facial pain 
2. Other headache, cranial neuralgia, central or primary facial pain  
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A brief summary of the definitions and symptom clusters of the most common forms of 
primary headaches is given below. For a full definition of the other headache conditions the 
reader can refer to the The International Classification of Headache Disorders 2nd edition. 
ICHD-2 diagnostic criteria for migraine without aura8 
A. At least five attacks fulfilling criteria B–D 
B. Headache attacks lasting 4–72 hours and occurring on < 15 days/month (untreated or 
unsuccessfully treated) 
C. Headache has at least two of the following characteristics 
1. Unilateral location 
2. Pulsating quality 
3. Moderate or severe pain intensity 
4. Aggravation by or causing avoidance of routine physical activity (i.e. walking or climbing 
stairs) 
D. During headache at least one of the following: 
1. Nausea and/or vomiting 
2. Photophobia and phonophobia 
E. Not attributed to another disorder  
ICHD-2 diagnosis criteria for typical aura8 
A. At least two attacks fulfilling criteria B–E 
B. Fully reversible visual and/or sensory and/or speech symptoms but no motor weakness 
C. At least two of the following 
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1. Homonymous visual symptoms including positive features (i.e. flickering lights, spots and 
lines) and/or negative features (i.e. loss of vision) and/or unilateral sensory symptoms 
including positive features (i.e. pins and needles) and/or negative features (i.e. numbness) 
2. At least one symptom develops gradually over ≥ 5 min and/or different symptoms occur in 
succession 
3. Each symptom lasts ≥ 5 min and ≤ 60 min 
D. Headache that meets criteria B–D for migraine without aura begins during the aura or 
follows aura within 60 min 
E. Not attributed to another disorder 
ICHD-2 diagnostic criteria for tension-type headache 
A. At least 10 episodes fulfilling criteria B–E; headache < 1 day/month (episodic infrequent), 
1–14 days/month (episodic frequent), or ≥ 15 days/month (chronic) 
B. Headache lasting from 30 min to 7 days 
C. At least two of the following pain characteristics 
1. Pressing or tightening (non-pulsating) quality 
2. Mild or moderate intensity (may inhibit but does not prohibit activities) 
3. Bilateral location 
4. No aggravation by walking stairs or similar routine physical activity  
D. Both of the following 
1. No nausea or vomiting (anorexia may occur) 
2. Photophobia and phonophobia are absent, or one but not the other may be present 
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E. Not attributed to another disorder 
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Annexure 7 – Standard Treatment Guidelines 
 
STANDARD TREATMENT GUIDELINES AND ESSENTIAL MEDICINES LIST FOR 
SOUTH AFRICA. 2012 Edition (Hospital based)  
HEADACHE AND FACIAL PAIN SYNDROMES 
MIGRAINE 
DESCRIPTION 
Episodic headache, usually focal in nature, which may occur with or without an aura. It is 
usually accompanied by nausea and vomiting. Several variants of migraine also occur. 
GENERAL MEASURES 
Reassure patient that this is a benign condition. Attempt to identify any precipitating factors 
or food allergies from the history (although this is usually unrewarding), and try to diminish 
patterns of tension. 
MEDICINE TREATMENT 
Acute treatment 
Initiate therapy during the attack or at the onset of the headache. 
Analgesics, e.g.: 
• Paracetamol, oral, 1g 4–6 hourly when required to a maximum of 4 doses per 24 hours. 
OR 
NSAIDs, e.g.: 
• Ibuprofen, oral, 800 mg immediately then 8 hourly, if needed. If severe and not responding 
to therapy above: 
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• Morphine, IM, 10 mg as a single dose. 
For nausea: 
• Metoclopramide, oral/IM, 10 mg 8 hourly.  
Prophylaxis 
Regular, daily, prophylactic therapy is advised if: 
» attacks are frequent, i.e. more than 2–3 per month, or  
» severe, causing a significant amount of disability, or 
» attacks are long lasting. 
Also consider for patients who tolerate therapy for acute attacks poorly. 
• Amitriptyline, oral, 10–25 mg at bedtime. 
o Titrate dose up to adequate response. 
o More than 75–150 mg as a single bedtime dose is seldom required. 
OR 
• Propranolol, oral, 20–80 mg 12 hourly. 
Note: 
The evidence for using atenolol for this indication is limited. 
OR 
• Carbamazepine, oral. 
o Start with 100 mg 12 hourly. 
o Increase every two weeks up to a maximum of 400 mg 12 hourly. 
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Note: 
Only about half of patients will respond to one of these agents and this response may take 1 
to 2 months to occur. 
REFERRAL 
» Patients with unexplained neurological signs, additional risk factors for an alternate 
diagnosis, such as immune deficiency, or an atypical short history require brain imaging. 
» Sudden onset of a first severe headache, even if it resembles migraine, as this may 
indicate serious organic pathology, such as subarachnoid haemorrhage. 
» Acute migraine, not responding to treatment. 
» Recurrent migraine not controlled with prophylactic therapy. 
 CLUSTER HEADACHE 
DESCRIPTION 
Repetitive episodes of excruciating headache typically of short duration (up to 2 hours) in 
clusters for weeks to months at a time. Typically the headache is of sudden onset, unilateral 
during the specific cluster, and quickly reaches a climax. Associated redness of the eye with 
lacrimation and rhinorrhoea occurs. 
MEDICINE TREATMENT 
Oxygen inhalation may abort some episodes. Analgesics are ineffective in this indication. To 
induce rapid remission in patients with episodic cluster headache:  
• Prednisone, oral, 40 mg daily for 5–10 days. 
o Tapering is not necessary when the above duration is used. 
OR 
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• Verapamil, oral, 40 to 80 mg 8 hourly. 
REFERRAL 
» Inadequate response to treatment. 
 TRIGEMINAL NEURALGIA 
DESCRIPTION 
Severe, very short lived stabs of facial pain in the sensory trigeminal distribution. It is 
important in the diagnostic workup to exclude intracranial mass lesions, which may impinge 
on the trigeminal nerve. 
MEDICINE TREATMENT 
• Carbamazepine, oral, 100 mg 2–3 times daily, initial dose 
o Increase dose slowly. Doses of up to 1 200 mg daily may be required. 
o After exacerbation, reduce to maintenance dose of 400–800 mg daily. 
REFERRAL 
» Neuro-imaging, if not available locally. 
» Poor response to single drug therapy. 
 TENSION HEADACHE 
DESCRIPTION 
Headache over the back of the head, but sometimes over the entire head, described as a 
tight band around the head, usually worse in the afternoon. 
GENERAL MEASURES 
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Consider use of relaxation techniques. The importance of this diagnosis is the exclusion of 
other, more sinister conditions. Exclude analgesia overuse headache. 
MEDICINE TREATMENT 
• Amitriptyline, oral, 10–75 mg at night. 
REFERRAL 
» Atypical pain, suggestive of alternate diagnosis. 
» Poor response to therapy. 
 IDIOPATHIC (BENIGN) INTRACRANIAL HYPERTENSION 
(PSEUDOTUMOUR CEREBRI) 
DESCRIPTION 
Patients present with symptoms (chronic headache and sometimes eventual visual loss due 
to persistent papilloedema) and signs (papilloedema) of raised intracranial pressure in the 
absence of any structural intracranial abnormality or abnormal CSF composition. 
Diagnosis 
All patients should have neuro-imaging (CT scan). 
» If this is normal, i.e. the absence of structural lesions or hydrocephalus, perform a lumbar 
puncture.  
» Diagnosis is confirmed by the presence of raised CSF pressure > 20 cm H20. 
GENERAL MEASURES 
Not all patients require definitive treatment. Regular monitoring of visual fields is crucial. 
Weight loss. Repeated lumbar punctures. Consider surgery if there is progression of visual 
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defects, despite medical therapy, visual loss at onset or severe papilloedema. Stop drugs 
known to be associated with benign intracranial hypertension. 
MEDICINE TREATMENT 
All patients need to be discussed with a specialist. For visual involvement, persistent 
headaches, or severe papilloedema: 
• Acetazolamide, oral, 1–2 g daily. 
OR 
• Furosemide, oral, 40 mg daily. 
OR 
• Hydrochlorothiazide, oral, 25 mg daily. 
REFERRAL 
» For neuro-imaging, if not available locally. 
» Visual symptoms or deterioration of visual fields for ophthalmology evaluation. 
» Patients not responding to therapy or in need of surgical management 
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Annexure 8 – Methodology Flow Chart 
         
              STUDY DESIGN                                                                        STUDY SITE 
Quantitative/Prospective/Cross sectional                                             Dr. Yusuf Dadoo Hospital  
 
                      STUDY SAMPLE                                                             STUDY POPULATION 
  All patients who present with headache                           Undifferentiated patients in OPD 
 
 
                                                    All OPD patients register with the nurse 
 
 
 CONVENIENCE SAMPLING                           EXCLUDED                           Underage <18 years   
Only patients with headache                Patients without headache                 Do not consent/critically ill 
directed to the researcher 
          
 
 INCLUDED                                                                                                                                                         
Adult patients with headache                                                  Consult with the researcher 
Consent to participate                                                                  
                                                                                      Patient goes back to the Nurse  
 
Nurse sends patient to the pharmacy                                                   Patient goes to pharmacy/referred  
  
              MEASURING TOOL 
Interview using a directed questionnaire                                                  DATA INTERPRETATION 
                                                                                                                           Categorical Variables 
DATA ANALYSIS                                                                                   Continuous variables 
    MS Excel                                                                                                        95% CI and P-value                                                                                         
Continuos variables  
